These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3486471)

  • 1. Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II.
    Fay PJ; Kawai Y; Wagner DD; Ginsburg D; Bonthron D; Ohlsson-Wilhelm BM; Chavin SI; Abraham GN; Handin RI; Orkin SH
    Science; 1986 May; 232(4753):995-8. PubMed ID: 3486471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial cell synthesis of von Willebrand antigen II, von Willebrand factor, and von Willebrand factor/von Willebrand antigen II complex.
    McCarroll DR; Levin EG; Montgomery RR
    J Clin Invest; 1985 Apr; 75(4):1089-95. PubMed ID: 3872883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells.
    Wagner DD; Fay PJ; Sporn LA; Sinha S; Lawrence SO; Marder VJ
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):1955-9. PubMed ID: 3494248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.
    de Romeuf C; Mazurier C
    Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor storage and multimerization: 2 independent intracellular processes.
    Haberichter SL; Fahs SA; Montgomery RR
    Blood; 2000 Sep; 96(5):1808-15. PubMed ID: 10961880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 1-integrin-mediated adhesion of melanoma cells to the propolypeptide of von Willebrand factor.
    Takagi J; Sudo Y; Saito T; Saito Y
    Eur J Biochem; 1994 Jun; 222(3):861-7. PubMed ID: 7517867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porcine platelet von Willebrand antigen II (vW AgII): inhibitory effect on collagen-induced aggregation and comparative distribution with human platelets.
    Royo T; Vidal M; Badimon L
    Thromb Haemost; 1998 Oct; 80(4):677-85. PubMed ID: 9798990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies.
    Vischer UM; Wagner DD
    Blood; 1994 Jun; 83(12):3536-44. PubMed ID: 8204880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for extracellular processing of pro-von Willebrand factor after infusion in animals with and without severe von Willebrand disease.
    Turecek PL; Pichler L; Auer W; Eder G; Varadi K; Mitterer A; Mundt W; Schlokat U; Dorner F; Drouet LO; Roussi J; van Mourik JA; Schwarz HP
    Blood; 1999 Sep; 94(5):1637-47. PubMed ID: 10477688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro multimerization of von Willebrand factor is triggered by low pH. Importance of the propolypeptide and free sulfhydryls.
    Mayadas TN; Wagner DD
    J Biol Chem; 1989 Aug; 264(23):13497-503. PubMed ID: 2788160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor.
    Leyte A; Voorberg J; Van Schijndel HB; Duim B; Pannekoek H; Van Mourik JA
    Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):257-61. PubMed ID: 1900418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans.
    Borchiellini A; Fijnvandraat K; ten Cate JW; Pajkrt D; van Deventer SJ; Pasterkamp G; Meijer-Huizinga F; Zwart-Huinink L; Voorberg J; van Mourik JA
    Blood; 1996 Oct; 88(8):2951-8. PubMed ID: 8874191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic cleavage of the precursor of von Willebrand factor is not essential for multimer formation.
    Verweij CL; Hart M; Pannekoek H
    J Biol Chem; 1988 Jun; 263(17):7921-4. PubMed ID: 3131331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro processing of recombinant pro-von Willebrand factor.
    Turecek PL; Váradi K; Schlokat U; Pichler L; Dorner F; Schwarz HP
    Histochem Cell Biol; 2002 Feb; 117(2):123-9. PubMed ID: 11935288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary structure of the factor VIII binding domain of human, porcine and rabbit von Willebrand factor.
    Lavergne JM; Piao YC; Ferreira V; Kerbiriou-Nabias D; Bahnak BR; Meyer D
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1019-24. PubMed ID: 8352759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease.
    Lison S; Dietrich W; Spannagl M
    Anesth Analg; 2012 Jan; 114(1):73-81. PubMed ID: 22025497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propolypeptide of von Willebrand factor is a novel ligand for very late antigen-4 integrin.
    Isobe T; Hisaoka T; Shimizu A; Okuno M; Aimoto S; Takada Y; Saito Y; Takagi J
    J Biol Chem; 1997 Mar; 272(13):8447-53. PubMed ID: 9079671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormality of the N-terminal portion of von Willebrand factor in type IIA and IIC von Willebrand disease.
    Takahashi Y; Kalafatis M; Girma JP; Meyer D
    Thromb Haemost; 1988 Dec; 60(3):498-505. PubMed ID: 3266380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of human von Willebrand factor.
    Verweij CL
    Haemostasis; 1988; 18(4-6):224-45. PubMed ID: 3069640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.